Research Article
Volume 7 Issue 3 - 2020
Major Cardiovascular Diseases and its Clinical Diagnosis
Mehtab Muhammad Aslam1*, Noor-ul-Ain2 and Peng Gang3
1Center for Plant Water-Use and Nutrition Regulation, College of Life Sciences, Joint International Research Laboratory of Water and Nutrient in Cops, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China
2FAFU and UIUC-SIB Joint Center for Genomics and Biotechnology, College of Agriculture, Fujian Agriculture and Forestry University, Fuzhou, China
3Horticulture Plant Biology and Metabolic Center, Haixia Institute of Science and Technology (HIST), Fujian Agriculture and Forestry University, Fuzhou, China
*Corresponding Author: Mehtab Muhammad Aslam, Center for Plant Water-Use and Nutrition Regulation, College of Life Sciences, Joint International Research Laboratory of Water and Nutrient in Cops, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China.
Received: December 24, 2019; Published: February 17, 2020


The main aim of cardiovascular research is to evaluate CVD chance of occurrence by clinical record, general practices and evaluate changes of CVD chance in population. Cardiovascular disease is major subscriber to the occurrence of atherosclerosis and many other diseases the most common which are discussed in this study are Heart failure, Coronary artery disease, Cardiomyopathies, Valvular heart disease, Congenital heart disease, Endocarditis inflammation, Coronary heart disease, hypertensive heart disease, Pulmonary artery disease, Cardiac dysrhythm, Myocarditis inflammation, Inflammatory heart disease, Cardiomegaly inflammation and rheumatic high fever. CVD remains the major cause of death in United States and worldwide 20% worldwide deaths per year. In low and middle income countries about 80%CVD deaths take place. For use in health care facilities, no guidelines are available. Annually more people die from CVDs than from any other cause. Most cardiovascular diseases can be prohibited by give a lecture about behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population wide strategies. Cardiovascular disease person or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidemia etc.) need early detection and management using counseling and medicines. CVD found in both Youngers and adult. In cardiovascular system the abnormal function of arteries, heart, veins and capillaries directly leads to different cardiovascular disorder the most common are discussed in this review. It is estimated that, cardiovascular is the main reason of large number of death all over the world and also in established countries. The total amount of deaths caused by CVD in 2005 (especially rheumatic heart disease, coronary heart disease, stroke, and heart failure) has increasing 17.5 million all over the world from the 14.4 million by 1990. Cardiovascular risk factors are: (1) sex, age (2) systolic and diastolic blood pressure (3) history of dyslipidemia (4) diabetes and (5) smoking status. The risk of CVD increased with age of the patient. Regeneration of damaged myocardium and treatment of CVDs is exhibit by great stems cells-based therapy. For the treatment of cardiovascular disease, Ultrasound (US) has been considered as a valuable diagnostic tool and stem cell based therapy is also used for the transformation of drug at the site of infection or injury. Traditional cell-based therapy is evolved in the totipotent cells, which is able to distinguish into various mature cells forming functional tissue required for embryonic formation. Other relevant new therapy utilization of pluripotent or multipotent (adult cells), are conceivable for making specialized mature cell lines. The treatment of cardiovascular disease has richness in life saving and better improvement in the condition of patient, also associated with an aging population, which directly leads to outbreak of heart failure which is a type of disorder with increased rate of mortality and morbidity.

Keywords: CVD; Clinical Diagnosis; Nanotechnology


  1. Anthea M., et al. “Human Biology and Health”. Englewood Cliffs, New Jersey (1993).
  2. Dantas AP., et al. “Vascular aging: facts and factors”. Frontiers in Physiology 3 (2012).
  3. Eakin CM., et al. “Caribbean corals in crisis: record thermal stress, bleaching, and mortality in 2005”. PloS One 5 (2010): e13969.
  4. Ndumele CD., et al. “Publication of recruitment methods in focus group research of minority populations with chronic disease: a systematic review”. Journal of Health Care for the Poor and Underserved 22 (2011): 5-23.
  5. Carandang R., et al. “Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years”. Journal of the American Medicine Association 296 (2006): 2939-2946.
  6. Yeh RW and Go AS. “Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities”. Archives of Internal Medicine 170 (2010): 759-764.
  7. Hovorka R., et al. “Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial”. The Lancet 375 (2010): 743-751.
  8. Amar J., et al. “Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the DESIR study”. PLoS One 8 (2013): e54461.
  9. Christoforou N and Gearhart JD. “Stem cells and their potential in cell-based cardiac therapies”. Progress in Cardiovascular Diseases 49 (2007): 396-413.
  10. Silva GV., et al. “Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model”. Circulation 111 (2005): 150-156.
  11. Dufourcq P., et al. “Secreted Frizzled‐Related Protein‐1 Enhances Mesenchymal Stem Cell Function in Angiogenesis and Contributes to Neovessel Maturation”. Stem Cells 26 (2008): 2991-3001.
  12. Kanneganti T-D., et al. “Intracellular NOD-like receptors in host defense and disease”. Immunity 27 (2007): 549-559.
  13. Beaglehole R and Bonita R. “Global public health: a scorecard”. The Lancet 372 (2008): 1988-1996.
  14. Barone E., et al. “Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action”. Pharmacological Research 63 (2011): 172-180.
  15. Dipchand AI., et al. “The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric heart transplantation report—2013. focus theme: age”. The Journal of Heart and Lung Transplantation 32 (2013): 979-988.
  16. Lund LH., et al. “The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report—2013. focus theme: age”. The Journal of Heart and Lung Transplantation 32 (2013): 951-964.
  17. Kushwaha SS., et al. “Restrictive cardiomyopathy”. New England Journal of Medicine 336 (1997): 267-276.
  18. Olin JW and Sealove BA. “Peripheral artery disease: current insight into the disease and its diagnosis and management”. In Proceedings of Mayo Clinic Proceedings (2010): 678-692.
  19. Frohlich ED., et al. “The heart in hypertension”. New England Journal of Medicine 327 (1992): 998-1008.
  20. Lee C., et al. “Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension”. Circulation 126 (2012): 2601-2611.
  21. Jeffery T and Morrell N. “Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension”. Progress in Cardiovascular Diseases 45 (2002): 173-202.
  22. Clark RA., et al. “Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis”. British Medical Journal (2007).
  23. Polisena J., et al. “Home telemonitoring for congestive heart failure: a systematic review and meta-analysis”. Journal of Telemedicine and Telecare 16 (2010): 68-76.
  24. Clarke M., et al. “Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis”. Journal of Telemedicine and Telecare 17 (2011): 7-14.
  25. Inglis SC., et al. “Which components of heart failure programmes are effective? A systematic review and meta‐analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane Review”. European Journal of Heart Failure 13 (2011): 1028-1040.
  26. Esfandiarei M., et al. “Dilated cardiomyopathy and other cardiomyopathies”. Cardiovascular Genetics and Genomics for the Cardiologist 55 (2007).
  27. Nishimura RA., et al. “ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons”. Journal of the American College of Cardiology 52 (2008): 676-685.
  28. Hoffman JI and Kaplan S. “The incidence of congenital heart disease”. Journal of the American College of Cardiology 39 (2002): 1890-1900.
  29. Zhang T., et al. “Fast pediatric 3D free‐breathing abdominal dynamic contrast enhanced MRI with high spatiotemporal resolution”. Journal of Magnetic Resonance Imaging 41(2015): 460-473.
  30. Feldman RD. “American health care: government, market processes, and the public interest”. Transaction Publishers: 2000.
  31. Butler D. “Translational research: crossing the valley of death”. Nature News 453 (2008): 840-842.
  32. Wang TJ., et al. “Multiple biomarkers for the prediction of first major cardiovascular events and death”. New England Journal of Medicine 355 (2006): 2631-2639.
  33. Rangappa S., et al. “Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes”. The Annals of Thoracic Surgery 75 (2003): 775-779.
  34. Bakeeva L., et al. “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS-and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)”. Biochemistry (Moscow) 73 (2008): 1288-1299.
  35. Aguirre A., et al. “Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal”. Nature 467 (2010): 323-327.
  36. Khubutiya MS., et al. “Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury”. Cytotherapy 16 (2014): 579-585.
  37. Moruzzi VL. et al. “Calculated electronic properties of metals”. Elsevier (2013).
  38. Zarin DA., et al. “The ClinicalTrials. gov results database—update and key issues”. New England Journal of Medicine 364 (2011): 852-860.
  39. Sekine H., et al. “Myocardial tissue engineering: toward a bioartificial pump”. Cell and Tissue Research 347 (2012): 775-782.
  40. Weis SM and Cheresh DA. “Tumor angiogenesis: molecular pathways and therapeutic targets”. Nature Medicine 17 (2011): 1359-1370.
  41. Luissint A-C., et al. “Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation”. Fluids Barriers CNS 9 (2012): 23.
  42. Król S., et al. “PBDEs in environmental samples: Sampling and analysis”. Talanta 93 (2012): 1-17.
  43. Kuruvilla L and Kartha CC. “Molecular mechanisms in endothelial regulation of cardiac function”. Molecular and Cellular Biochemistry 253 (2003): 113-123.
  44. Weis SM., et al. “Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK”. The Journal of Cell Biology 181 (2008): 43-50.
  45. Luissint A-C., et al. “JAM-related proteins in mucosal homeostasis and inflammation”. In Proceedings of Seminars in Immunopathology (2014): 211-226.
Citation: Mehtab Muhammad Aslam.,et al. “Major Cardiovascular Diseases and its Clinical Diagnosis”. EC Cardiology 7.3 (2020): 01-25s.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.